SCI REP-UK 润色咨询

Scientific Reports

出版年份:2011 年文章数:160514 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:9.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    9小时前 萝布 来自湖北省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:基础
    经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-04 ms7957059236203375 来自四川省

    偏重的研究方向:肿瘤
    经验分享:一月份投,二月份就接收了,有没有想问的!

    11

    展开11条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-14 ms4000001202980961 来自北京

    偏重的研究方向:肿瘤
    经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-25 ms2000001772107411 来自广东省

    这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-25 ms7000000723272542 来自四川省

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:心理学
    经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-22 ms6000001827613117 来自安徽省

    审稿速度:12.0 | 投稿命中率:5.0
    偏重的研究方向:肝硬化;门脉高压
    经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-22 ms7000000307422374 来自福建省

    两个月还没找到审稿人

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-18 SENOMEGA 来自江苏省

    审稿速度:24.0 | 投稿命中率:50.0
    偏重的研究方向:数据分析
    经验分享:用了一年多时间,太不容易了,分享一下过程吧
    Publishing and rights
    Submission status Date
    Submission is in publishing and rights
    18 Mar 2024
    Peer review
    Submission status Date
    Submission accepted
    18 Mar 2024
    Submission under peer review
    25 Feb 2024
    Submission passed technical check
    25 Feb 2024
    Amendment received
    24 Feb 2024
    Revision received
    23 Feb 2024
    Submission under peer review
    21 Feb 2023
    Technical check
    Submission status Date
    Submission passed technical check
    21 Feb 2023
    Submission is under technical check
    20 Feb 2023
    Submission received
    Submission status Date
    Submission received
    20 Feb 2023

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-01-02 Dehors 来自江苏省

    偏重的研究方向:生物信息学;肿瘤;Cancer
    经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report)

    10

    展开10条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:基础<br>经验分享:2023年6月4日投稿,2024年3月25日接收。9个多月,终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=9小时前, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向:肿瘤<br>经验分享:一月份投,二月份就接收了,有没有想问的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2193260, encodeId=55b72193260af, content=偏重的研究方向:肿瘤<br>经验分享:最近大家的状态都乱码了,大家都有点慌,我发邮件问了编辑,编辑也回复的,附在下边。我的理解是今年sr的系统应该是换状态了,现在的这个状态应该是包含了之前我们见过的很多状态,耐心等待吧,有消息应该会通知到邮箱 Dear Prof., Thank you for your email and please accept my sincerest apologies for the lack of update on your paper. Your manuscript has cleared the quality check stage and it is going through the peer review process. So afar we have secured one reviewer and the editor is inviting more reviewers in order to sure at least one more reviewer. I completely understand that this delay is unacceptable and I cannot apologise enough for this. Please be assured that we are always in regular contact with the handling Editor and doing all we can to ensure your manuscript is expedited through the publishing process as swiftly as possible. We hope to get a decision to you soon and your patience while we do this will be greatly appreciated. Please do not hesitate to contact us again if there is anything we may be able to help you with, and please accept my apologies once more. Kind Regards, Prasad Bhalerao, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=611f6487300, createdName=ms4000001202980961, createdTime=Thu Mar 14 19:13:57 CST 2024, time=2024-03-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗?水平还ok,可能创新性一般,写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195191, encodeId=487021951913a, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:心理学<br>经验分享:2023年5月说通过了初审,然后接下来三个月一直没找到审稿人,发邮件无回复,2024年1月退稿。前后8个月,很无语,不多说了,慎投!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92418565233, createdName=ms7000000723272542, createdTime=Mon Mar 25 11:34:53 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194781, encodeId=1bf12194e8145, content=审稿速度:12.0 | 投稿命中率:5.0<br>偏重的研究方向:肝硬化;门脉高压<br>经验分享:2023年8月投稿,2024年1月给了1个审稿人意见,返修再投,2024年3月拒稿。一共历时7个月。2024年1月的审稿人,和2024年3月的审稿人不是一个人,对文章的观点完全不一样,白白浪费时间。找不到合适的审稿人是关键问题,不是相关领域的专家都搞不清文章在讲什么。审稿太慢,是一个问题,发邮件催促没有意义。前后是不同的审稿人,太可怕。慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a5a8221226, createdName=ms6000001827613117, createdTime=Fri Mar 22 22:19:09 CST 2024, time=2024-03-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2193895, encodeId=aa8c2193895cc, content=审稿速度:24.0 | 投稿命中率:50.0<br>偏重的研究方向:数据分析<br>经验分享:用了一年多时间,太不容易了,分享一下过程吧<br>Publishing and rights<br>Submission status Date<br>Submission is in publishing and rights<br>18 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>18 Mar 2024<br>Submission under peer review<br>25 Feb 2024<br>Submission passed technical check<br>25 Feb 2024<br>Amendment received<br>24 Feb 2024<br>Revision received<br>23 Feb 2024<br>Submission under peer review<br>21 Feb 2023<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>21 Feb 2023<br>Submission is under technical check<br>20 Feb 2023<br>Submission received<br>Submission status Date<br>Submission received<br>20 Feb 2023<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f83c4883792, createdName=SENOMEGA, createdTime=Mon Mar 18 15:21:02 CST 2024, time=2024-03-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向:生物信息学;肿瘤;Cancer<br>经验分享:- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192926, encodeId=69e621929264f, content=大佬们,现在版面费是第三方收取么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Wed Mar 13 10:38:38 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省)]
    2024-03-13 ms7957059236203375 来自四川省

    大佬们,现在版面费是第三方收取么?

    4

    展开4条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分